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Organotin(IV) complexes with o- or p-hydroxybenzoic acids (o-H2BZA or p-H2BZA) of formulae [R2Sn(HL)2]( w h e r eH 2L =
o-H2BZA and R = Me- (1), n-Bu- (2)); [R3Sn(HL)] (where H2L = o-H2BZA and R = n-Bu- (3), Ph- (4)o rH 2L = p-H2BZA
and R = n-Bu- (5), Ph- (6)) were synthesized by reacting a methanolic solution of di- and triorganotin(IV) compounds with an
aqueous solution of the ligand (o-H2BZA or p-H2BZA) containing equimolar amounts of potassium hydroxide. The complexes
were characterized by elemental analysis, FT-IR, Far-IR, TGA-DTA, FT-Raman, M¨ ossbauer spectroscopy, 1H, 119Sn-NMR, UV/Vis
spectroscopy, and Mass spectroscopy. The X-ray crystal structures of complexes 1 and 2 have also been determined. Finally, the
inﬂuence of these complexes 1–6 upon the catalytic peroxidation of linoleic acid to hydroperoxylinoleic acid by the enzyme
lipoxygenase (LOX) was kinetically studied and the results showed that triorganotin(IV) complex 6 has the lowest IC50 value.
Also complexes 1–6 were studied for their in vitro cytotoxicity against sarcoma cancer cells (mesenchymal tissue) from the Wistar
rat, and the results showed that the complexes have high activity against these cell lines with triphenyltin((IV) complex 4 to be the
most active one.
Copyright © 2009 Mohamed A. Abdellah et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Organotin compounds have many important applications
and uses [1, 2]. Commercially, organotin compounds are
usedasindustrialandagriculturalbiocidesbecausetheyhave
high antifungal properties [3, 4]. The in vitro fungicidal or
antibacterial properties of organotins have been found to
exhibit the general order of activity: RSnX3 < R2SnX2 <
R4Sn   R3SnX, with the anionic X group to exert little
inﬂuence on activity [5, 6]. The combination of two biolog-
ically active entities, however, in the same molecule could
enhance their activity [7]. For example, triphenyltin(IV)
derivatives of phthalic acid and salicaldehydehavesigniﬁcant
activity toward a range of fungi [8, 9]. Recently, interests
in organotin(IV) carboxylates are increasing due to their
possible medical uses as antitumor agents [10]. For example,
the ﬂuoro-substituted carboxylate ligands with di- and
triorganotins produced several antitumor active compounds
[11]. Hubert et al. concluded that antitumor active tin
compounds possess available coordination positions around
tin atom and also have relatively stable ligand-tin bonds with
low hydrolytic decomposition [12]. Thioamides-organotin
complexes, on the other hand, have shown high antitumor
activity, which is rather related to the ligand type and not
to the geometry of the compounds [13–17]. Given that the
antitumor action of Sn(IV) compounds may not be due2 Bioinorganic Chemistry and Applications
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to their direct interaction with DNA constituents [18–22],
their reaction with enzymes like lipoxygenase is always of
interestintheattempttoelucidatetheirmechanismofaction
[13–17]. This antitumor activity of the organotin complexes
followsthesameorderoflipoxygenaseinhibition,anenzyme
taking part in the inﬂammation mechanism and tumor
genesis [13–17].
With the aim to prepare new organotin(IV-)-based anti-
tumor compounds of o- or p-hydroxybenzoic acid (Schemes
1 (I) and (II), resp.), the synthesis of six organotin complexes
of formulae [R2Sn(HL)2]( w h e r eH 2L = o-H2BZA and R
= Me- (1), n-Bu- (2)) and [R3Sn(HL)], (where H2L = o-
H2BZA and R = n-Bu- (3), Ph- (4)o rH 2L = p-H2BZA,
and R = n-Bu- (5), Ph- (6)) and their characterization
by spectroscopic techniques (IR, Raman,1H-NMR, mass
Spectra, 119mSn M¨ ossbauer, UV/Vis), elemental analysis and
X-ray diﬀraction have been carried out. The inhibition
caused by these complexes toward the oxidation of linoleic
acid to hyperoxolinoleic acid by the enzyme lipoxygenase
(LOX) follow the order 6 > 4 > 5 > 2 > 1 > 3
and compared with their in vitro antitumor activity against
sarcoma cells, where the order is 4 > 6 > 5   3 =
2   1. Therefore, triorganotin compounds inhibit stronger
lipoxygenase and show higher activity against sarcoma cells
than diorganotins.
2. Results andDiscussion
2.1. General Aspects. Organotin(IV) complexes 1–6 have
been synthesized by reacting a methanolic solution of organ-
otin chloride with an aqueous solution of the appropriate
amounts of 2- or 4-hydroxybenzoic acid containing an
equimolar amount of potassium hydroxide as shown in (1)
and (2):
R2SnCl2 +2 H 2L+2 K OH
MeOH/H2O
− −−−−−− →
R2Sn(HL2)+2K C l+2H 2O
H2L = o-H2BZA and R = Me- (1), n-Bu- (2)
(1)
R3S n Cl+H 2L+K OH
MeOH/H2O
− −−−−−− →
R3S n (HL)+K C l+H 2O
H2L = o-H2BZA and R = n-Bu- (3), Ph- (4)o r
H2L = p-H2BZA and R = n-Bu- (5), Ph- (6).
(2)
Complexes1-2werepreparedwithanalternativemethod
of the one used previously for the synthesis of these
complexes [23, 24]. Complexes 1–6 are air-stable powders
soluble in methanol, ethanol, and DMSO solvents. Crystals
suitableforX-rayanalysiswereobtainedbyslowevaporation
of methanol/acetonitril solutions for compounds 1 and 2.
2.2. Thermal Analysis. The TGA/DTA data curves for com-
plexes 1-2 show that they decompose generally in one
stage. Thus, thermal analysis in ﬂowing nitrogen shows that
complex 1 decomposes between 125 and 315
◦C with 72%
mass loss which corresponds to the methyl groups of the
metal and the ligand molecules (the calculated mass loss is
72%), compound 2 decomposes between 35 and 490
◦Cw i t h
74% mass loss due to the butyl groups of the metal and
the ligand molecules (the calculated mass loss is 76.50%)
(Scheme 2).
The TGA/DTA data in ﬂowing nitrogen data curves for
complexes 3–6 show that they decompose generally in two
stages. The ﬁrst stage of decomposition of compound 3
lies between 20 and 255
◦C that corresponds to 13% mass
loss of one of the metal butyl groups (the calculated mass
loss is 13%), compound 4 decomposes between 35 and
215
◦C with 16% mass loss of one of the metal phenyl
groups (the calculated mass loss is 16%), compound 5
decomposes between 25 and 255
◦C that corresponds to
13% mass loss of one of the metal butyl groups (the
calculated mass loss is 13%), and compound 6 decomposes
between 25 and 177
◦C with 15% mass loss of one of the
metal phenyl groups (the calculated mass loss is 16%). The
second stage of decomposition is between 255 and 400
◦C
in case of 3 which corresponds to 44% mass loss of the
ligand (o-hydroxybenzoic acid) and another metal butyl
group (the calculated mass loss is 45%), between 215 and
500
◦C( 4) corresponding to 43% mass loss of the ligand
(o-hydroxybenzoic acid) and another metal phenyl group
(the calculated mass loss is 42%), compound 5 decomposes
between 255 and 412
◦C which corresponds to 45.60% mass
loss of theligand (p-hydroxybenzoic acid) andanother metal
butylgroup(thecalculatedmasslossis45%),andcompound
6 decomposes between 177 and 435
◦C with 42% mass loss
which corresponds to the ligand (p-hydroxybenzoic acid)
and another metal phenyl group (the calculated mass loss is
42%) (Scheme 2).Bioinorganic Chemistry and Applications 3
Table 1: Characteristic vibration bands (cm−1) of the o- or p-HBZA ligands and their complexes 1–6.
Compound Infrared Raman Ref.
v(OH) v(CH) vas, vsy(COO) v(Sn-C) v(Sn-C) v(Sn-O) v(Sn-C)
o-H2BZA 3282 1656, 1324 [25]
o-NaHBZA 1577, 1373 [26]
1 3467 2817-2705 1631, 1388 580, 536 446 — —
2 3450 2928-2869 1628, 1419 562, 530 435 — —
3 3450 2957-2364 1633, 1352 564, 538 445 — —
4 3447 3063 1636, 1356 600, 533 420 — —
p-H2BZA 3382 — 1687, 1360 — — — — [27]
p-NaHBZA 3382 1547, 1416 [27]
5 3439 2958-2922 1613, 1351 606, 509 457 410 520
6 3433 3068 1615, 1431 569, 511 438 450 618
[R2Sn(HL)2][ S n ]
−2H2L, −2RH
H2L = o-H2BZA and R = Me- (1), n-Bu- (2)
[R3Sn(HL)] [R2Sn(HL)] [RSn]
−RH −H2L, −RH
H2L = o-H2BZA and R = n-Bu- (3), Ph- (4)o r
H2L = p-H2BZA and R = n-Bu- (5), Ph- (6)
Scheme 2
2.3. Spectroscopy. Vibrational spectroscopy: characteristic
infraredbandsofthecomplexes1–6andtheligandsarelisted
in Table 1.
The IR spectra of the complexes 1–6 show vibrational
bands at 3467 1, 3450 2, 3450 3, 3447 4, 3439 5, and 3433
6cm−1, which are assigned to v(phenolic OH) [28, 29]. The
corresponding vibrational bands v(O-H) of the free ligands
appear at 3282 and 3382cm−1 for o-H2BZA or p-H2BZA,
respectively [25, 27].
The vas(COO
−) vibration of the free ligand appears at
1656cm−1 while the vs(COO
−) at 1324cm−1 for o-H2BZA
[25], and the vas(COO
−) vibration of p-H2BZA ligand
appearsat1687cm−1 whilethevs(COO
−)at1360cm−1 [27].
The corresponding vas(COO
−)v i b r a t i o n sa r eo b s e r v e da t
1631 1, 1628 2, 1633 3, 1636 4, 1636 5, and 1617 6cm−1,
respectively. The bands at 1388 1, 1419 2, 1352 3, 1356 4,
1419 5, and 1347 6cm−1 are assigned to vs(COO
−). The Δv
[vas(COO
−)-vs(COO
−)] diﬀerence values of the free ligands
are (332cm−1 for o-H2BZA and 327cm−1 for p-H2BZA)
versus the corresponding values Δv for complexes 1–6 (243
1, 209 2, 281 3, 280 4, 217 5, and 270 6cm−1,r e s p . )s u p p o r t
the coordination of the ligand to the metal center through
the carboxylic acid group. Monodentate coordination of
the –COO
− group of the ligand to metal ions results in
signiﬁcantly higher Δv [vas(COO
−)-vs(COO
−)] diﬀerence
values than those observed for the ionic compounds of
the ligand [30], while when the ligand chelates, the Δv
[vas(COO
−)-vs(COO
−)] is considerably smaller than that
observed for its ionic compounds. For asymmetric bidentate
coordination, the values are in the range of monodentate
coordination [30]. When the –COO
− group bridges metal
ions, the Δv [vas(COO
−)-vs(COO
−)] value is higher than
that of the chelated ions and nearly the same as that
observed for ionic compounds [30]. In our case, the Δv
[vas(COO
−)-vs(COO
−)] values of the ionic compounds of
the o-NaHBZA and p-NaHBZA ligands (sodium salts) are
205cm−1 and 131cm−1,r e s p e c t i v e l y[ 26]. Therefore, in the
diorganotin complexes 1 and 2, where higher Δv values were
observed (243 1 and 209 2cm−1), an asymmetric bidentate
coordination of the ligand to the metal ion is expected (see
crystal structure, M¨ ossbauer spectra).The same is true in the
case of triorganotin complexes 3–6 with signiﬁcantly higher
Δv values than the corresponding ones of the sodium salts of
the ligands (281 3, 280 4, 217 5, and 270 6cm−1), indicating
clearly an asymmetric bidentate coordination mode of the
ligands and suggesting trigonal bipyramidal geometry for
complexes 3–6 in the solid state in agreement with the results
of M¨ ossbauer and 119Sn-NMR spectra.
Bands at 425–455cm−1 have been assigned to the
stretching vibration of Sn-O bonds. The corresponding ones
for complexes 1–6 are at 446 1, 435 2, 445 3, 420 4, 458
5, and 450cm−1 6 [25]. Bands at 600–500cm−1 have been
assigned to the antisymmetric and symmetric vibrations of
Sn-C bond. The corresponding ones for complexes 1–6 are
at 580, 536 1, 562, 530 2, 564, 538 3, 600, 533 4, 610, 509 5,
and 569, 511 6 [13–17]. No ν(Sn-Cl) vibration bands at 282
and 221cm−1 are observed in the far FT-IR of the complexes
[13].
119mSn M¨ ossbauer spectroscopy: solid state, 119mSn
M¨ ossbauer spectroscopic data of complexes 1-2 and 4–6 are
given in Table 2.
Theisomershiftsvaluesofcomplexes1–6areintherange
of δ 1.22 to 1.56mms−1 (Table 2), indicating that tin is in
the (4+) oxidation state in all cases [2, 32, 33]. The spectra of4 Bioinorganic Chemistry and Applications
Table 2: 119Sn M¨ ossbauer spectroscopic data for complexes 1–6 at 80K.
Molecule δ (mms−1) Δ (mms−1)C - S n - C ( ◦) angles ∗ Area (%) δ (mms−1) Δ (mms−1)C - S n - C ( ◦) angles ∗ Area (%)
1 1.22 3.09 130 56 1.33 3.65 148 44
2 1.31 3.53 143 29 1.56 3.68 149 71
4 1.34 2.93 100 — — —
5 1.24 2.48 100 — — —
6 1.44 3.18 100 — — —
∗The C-Sn-C angles (θ) are calculated from the equation following Δ = 4{R}[1−3cos2θ ·sin2θ]1/2, where the partial quadrupole splitting (p.q.s.), mm·s−1,
used in the calculations was ([R]-[Cl])oct =− 1.03 (R = Me, Bu) [31].
diorganotin(IV) complexes 1–2 consist of two symmetrical
Lorentzian doublets which indicate the presence of two tin
atoms in diﬀerent chemical environments with the same
ratio 1 : 1 (56 : 44% 1 and 29 : 71% 2,r e s p . ) .T h i sm a yb e
due to the presence of two diﬀerent isomers in the unit cells
withvariablebonddistances.Thequadrupolesplittingvalues
(Δ)o fc o m p l e x e s1-2 are 3.09mms−1 and 3.65mms−1 for 1
and 3.53mms−1 and 3.68mms−1 for 2, suggesting distorted
trans-R2 octahedral geometry (2.4–5.5mms−1)[ 2, 32, 33]
in the solid state in agreement with X-ray structures. The
calculated C-Sn-C angles (◦)f r o mM ¨ ossbauer spectra [31]
for the compounds 1 and 2 (Table 2) are 130
◦ for the highest
occurring isomer (56%) and 143
◦ for the lowest occurring
isomer (44%) in case of 1 and 148 (29%), 149
◦ (71%) in case
of 2. The values of C-Sn-C angles found from X-ray analysis
at 293K are 138.4(4)
◦ (1) and 144.0(3)
◦ (2), respectively (see
crystal structures).
The spectra of the triorganotin(IV) complexes 4–6 con-
sist of one symmetrical Lorentzian doublet which indicates
thepresenceofonetinatom.Thequadrupolesplittingvalues
in case of complexes 4–6 (Δ) are 2.93mms−1 4,2 . 4 8m ms −1
for 5, and 3.18mms−1 6 suggesting eq-R3 trigonalbipyrami-
dalgeometryaroundtinatom(2.5–4.0mms−1)[2,32,33]in
solid state in agreement with the geometry concluded from
119Sn-NMR spectra.
2.4. NMR Spectra. 1H-NMR spectra of complexes 1–6
showed a single resonance signal at 10.18 1, 10.16 2,9 . 9 1
3,9 . 9 54,9 . 8 75, and 9.89 6ppm, respectively, due to the
hydroxyl proton of the ligands (o-H2BZA or p-H2BZA) [34],
suggesting that the OH groups are not involved in bonding
with the tin atom. The two doublet signals at 7.83-7.79
and 6.82-6.79 1,7 .69-7.65 and 6.75-6.72 2,7 .72-7.69 and
6.73-6.70 3,7 .81-7.78 and 6.69-6.65 4,a n d7 .75-7.71 and
6.76-6.73 6ppm are assigned to the protons of the phenyl
group of the ligands a and b,r e s p e c t i v e l y( Scheme 1)[ 34].
In case of complex 1, the single signal at 0.83ppm is assigned
to the protons of the methyl group of the metal.
In case of complexes 6 and 7, 119Sn-NMR spectra were
also recorded. 119Sn-NMR spectra showed resonance signals
at −20.0( 6)a n d−212.0( 7)ppm, respectively. Although
the shift ranges are somewhat dependent on the nature
of the substituents at the tin atom the δ(119Sn) values
(in ppm) for R3Sn(IV) complexes with ﬁve-coordinated
Sn vary from +25 to −329ppm [33]. Thus, the tin(IV)
atoms are ﬁve coordinated in case of complexes 5 and 6,
and therefore the expected geometry arrangement around
triorganotin(IV), in solution, is suggested as trigonal bipyra-
midal.
Crystal, Molecular Structures of [(CH3)2Sn(OOCC6H4OH)2]
(1)a n d[(n-C4H9)2Sn(OOCC6H4OH)2] (2). The crystal
structures of complexes 1 and 2 had been determined
previously, at 193 and 295K with R% values of 6.4 and
3.8, respectively [23, 24]. However, we redetermined the
structureshereofboth1or2complexesatroomtemperature
(293K), with R% 2.18 and 4.83, respectively, for comparison
and in order to investigate the inﬂuence of the temperature
on their structures [33]. ORTEP diagrams of complexes 1
and 2 are shown in Figures 1 and 2.
Compounds 1 and 2 are covalent monomers in the
solid state with a distorted octahedral geometry around the
metal ion. Table 3 summarizes Sn-O and other selected bond
distancesandanglesfoundfororganotincomplexesreported
here and elsewhere [23, 24]. They diﬀer only slightly.
The Sn-O bond distances are 2.1060(18), 2.5147(15),
2.1079(15), and 2.577 ˚ Ai n1; 2.104(4), 2.564, 2.121(4), and
2.632 ˚ Ai n2 showing an asymmetric bidentate coordination
of the ligand to the Sn atom, as concluded in the IR
Section 2.3. The Sn-O bond distances found in 1 and 2 are
in agreement with the corresponding bond lengths found
in (CH3)2Sn(2,4,5-TF-3-MBA) 2 (2,4,5-TF-3-MBA = 2,4,5-
triﬂuoro-3-methoxybenzoic acid) 2.115(6)–2.656(6) ˚ A[ 11],
in (n-C4H9)2Sn(2,4,5-TF-3-MBA) 2, 2.128(3)–2.562(3) ˚ A
[11],andin(n-C4H9)2Sn(2,4-DHB)2 (2,4-DHB =dihydrox-
ybenzoato) 2.110(4)–2.559(4) ˚ A[ 35].
The O-Sn-O-C torsion angles found in complexes 1 and
2 were O271-Sn1-O171-C17 = 178.46(14)
◦ for 1 and (O272-
Sn1-O172-C17 = 177.6(4)
◦ for 2. This indicates the almost
coplanar arrangement of the two ligands with the tin atom.
Thus, the conformation around the tin atom is trans-C2, cis-
O2, cis O2. The value of the C-Sn-C angle (C31-Sn1-C41 =
138.44(11)
◦ in 1 and C31-Sn1-C41 = 143.8(2)
◦in 2)i m p l i e s
distortion of the octahedral structure.
In both complexes 1 and 2 there are intramolecular
hydrogen bonding interactions (O12···O172 = 2.620(2) ˚ A
and O22···O272 = 2.605(2) ˚ Af o r1,O 1 1 ···O171 =
2.621(7) ˚ Aa n dO 2 1 ···O271 = 2.622(5) ˚ Ai nc a s eo f2)
stabilizing the structures. Interesting strong Sn···O bond-
ing interaction (Sn1···O12 = 3.463 ˚ Ai nc a s eo f1 and
Sn1···O21 = 3.620 ˚ Ai nc a s eo f2) leads to the formation
o fd i m e r si nb o t hc a s e s( F i g u r e s1 and 2) which may
aﬀect the distortion of the octahedron observed. The sumBioinorganic Chemistry and Applications 5
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Figure 1: (a) Anisotropic ellipsoid representation of complex 1. The ellipsoids are drawn at 50% probability level. Selected bond distances
(˚ A) and bond angles (deg.): Sn1-O171 = 2.1069(18), Sn1-O172 = 2.5145(15), Sn1-O271 = 2.1086(15), Sn1-O272 = 2.577, Sn1-C31 =
2.086(3), Sn1-C41 = 2.091(3), O171-Sn1-O172 = 55.56(5), O172-Sn1-O272 = 83.39(6), and O271-Sn1-O171-C17 = 178.46(14). (b) Strong
Sn···O bonding interaction leads to the formation of a dimer.
of van der Walls radii of Sn and O varied between 3.80
and 4.17 ˚ A[ 36]. No such interaction was observed earlier
[23, 24].
Study of the Peroxidation of Linoleic Acid by the Enzyme
Lipoxygenase in the Presence of Complexes 1–6. The inﬂuence
of complexes 1–6 on the oxidation of linoleic acid by the
enzyme (LOX) was studied in a wide concentration range.
The degree of (LOX) activity (A, %) in the presence of these
complexes was calculated according to the method described
previously [13]. The IC50 values found for complexes 1–7
are 76 (1),4 8( 2),8 2(3),1 9( 4),2 4( 5),a n d1 1( 6)μm,
respectively. Thus, ﬁve coordinated (see Sn-NMR data)
triphenyl organotin compounds 6 and 4 are the most active
among this type of complexes showing the order of activity:
6 > 4 > 5 > 2 > 1 > 3. Moreover, triorganotin complexes
with p-H2BZA are found to be more active than the
corresponding compounds with p-H2BZA. These values are
also comparable to the ones found for other organotin(IV)
complexes [13–17] and signiﬁcantly higher than the
corresponding cisplatin. For example, the IC50 values found
for the organotin compounds tested toward (LOX) were
25μm[ ( n-Bu)3Sn(TBA) · H2O] (HTBA = 2-thiobarbituric
acid) [14], 26 and 14μm for [(C6H5)2SnCl(HMNA)] and
[(C6H5)3Sn(MNA)Sn(C6H5)3(acetone)] (H2MNA = 2-
mercapto-nicotinic acid) [13, 14], 19, 16, and 21μmf o r
[(C6H5)3Sn(MBZT)], [(C6H5)3Sn(MBZO)], [(C6H5)3Sn
(CMBZT)] [15]( M B Z T= 2-mercapto-benzothiazole,
MBZO = 2-mercapto-benzoxazole and CMBZT = 5-
chloro-2-mercapto-benzothiazole), 10, 13, and 14μmf o r
[(C6H5)2Sn(CMBZT)2], [(n-C4H9)2Sn(CMBZT)2], and
[(CH3)2Sn(CMBZT)2][ 15], and 61.3, 26.2, 20.5, and
16.9μm for [(CH3)2Sn(PMT)2], [(n-C4H9)2Sn(PMT)2],
[(C6H5)2Sn(PMT)2], and [(C6H5)3Sn(PMT)] (PMT =
2-mercapto-pyrimidine) [16]. Taking into account that
higher LOX inhibition activity is found to be related to the6 Bioinorganic Chemistry and Applications
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Figure 2: (a) Anisotropic ellipsoid representation of complex 2. The ellipsoids are drawn at 50% probability level. Selected bond distances
(˚ A) and bond angles (deg.): Sn1-O172 = 2.121(3), Sn1-O171 = 2.565, Sn1-O272 = 2.105(4), Sn1-O271 = 2.632, Sn1-C31 = 2.120(6), Sn1-
C41=2.111(5),O172-Sn1-O272=81.66(13),O171-Sn1-O271=170.01,andO272-Sn1-O172-C17=177.6(4)
◦.(b)StrongSn···Obonding
interaction leads to the formation of a dimer.
high cytotoxic activity against sarcoma cells, compound
4, 5, and 6 are expected to show such high activity (see
below).
2.5. Biological Tests. The high inhibitory activities of com-
plexes 1–10 against LOX activity found prompted us
to study the antiproliferative activity of them against
sarcoma cells and compare these data with their struc-
tural features. Complexes 1–6 were tested for cytotoxic
activity against leiomyosarcoma cells from the Wistar rat,
polycyclic aromatic hydrocarbons (PAH, benzo[a]pyrene)
carcinogenesis. Cytotoxic activities for complexes 1–6
were evaluated as % percentage of the cell survived in
variable concentrations of the complexes after 48 hours. The
IC50 values found were >2000 (1), 150 (2), 150 (3),5 – 1 0
(4),30–40 (5), and 25–35 (6)nm, respectively, indicatingBioinorganic Chemistry and Applications 7
Table 3: Selected bond distances (˚ A) and angles (deg) for the known diorganotin compounds with carboxylate ligands.
Complex Temperature (K) Sn-O (˚ A) Sn-C (˚ A) C-O (˚ A) C-Sn-C (◦)O - S n - O ( ◦)R e f .
1 293 2.1060(18) 2.089(3) 1.350(3) 138.4(4) 83.4(5) [∗]
2.5147(15) 2.093(3) 1.347(3) 139.1(5)
2.1079(15) 1.293(2) 55.7(5)
2.577 1.252(3)
2 293 2.104(4) 2.124(7) 1.288(6) 144.0(3) 81.68(15) [∗]
2.564 2.110(7) 1.237(7)
2.121(4) 1.245(8)
2.632 1.284(8)
(CH3)2Sn(o-HBZA)2 193 2.112(3) 2.092(5) 1.301(5) 138.2(2) 56.0(1) [24]
2.503(3) 2.092(5) 1.256(5) 82.9(1)
2.111(3) 1.292(5) 137.9(1)
2.577(3) 1.254(5) 138.9(1)
166.1(1)
55.0(1)
(n-C4H9)2Sn(o-HBZA)2 298 2.117(5) 2.122(9) 1.28(1) 143.9(3) 54.5(2) [23]
2.570(6) 2.105(9) 1.233(8) 81.6(2)
2.095(5) 1.294(9) 135.7(2)
2.630(6) 1.246(8) 136.1(2)
169.7(1)
54.1(2)
(n-C4H9)2Sn(2,4-DHB)2 298 2.559(4) 2.114(6) 1.267(6) 139.0(3) 54.9(1) [35]
2.110(4) 2.107(7) 1.281(6) 138.0(1)
2.508(4) 1.246(6) 82.8(1)
2.124(4) 1.294(7) 167.0(1)
137.7(1)
55.3(1)
(CH3)2Sn(2,4,5-TF-3-MBA) 2 298 2.115(6) 2.091(8) 1.262(9) 142.2(4) 135.8(2) [11]
2.656(6) 2.090(9) 1.234(10) 53.0(2)
2.118(5) 1.288(10) 171.17(18)
2.506(6) 1.229(10) 80.3(2)
55.6(2)
133.3(2)
(n-C4H9)2Sn(2,4,5-TF-3-MBA) 2 298 2.128(3) 2.109(5) 1.287(6) 147.5(2) 137.80(12) [11]
2.141(3) 2.107(5) 1.226(6) 54.58(12)
2.531(4) 1.281(6) 167.61(12)
2.562(3) 1.245(6) 82.60(13)
55.31(12)
137.08(12)
[∗]: This work; 2HB-O,O: 2-hydroxybenzoato-O,O ; 2,4-DHB: Dihydroxybenzoato; 2,4,5-TF-3-MBA: 2,4,5-Triﬂuoro-3-methoxybenzoic acid.
very strong cytotoxic activity against leiomyosarcoma
cells. In accordance with the LOX inhibition activity, the
ﬁve-coordinated triorganotin complexes 5, 3, and 6 showed
stronger antiproliferative activity against sarcoma cell lines
(see LOX inhibition activity). The order of activity of
complexes 1–6 is found to be 4 > 6 > 5   3 = 2   1.I ti s
noteworthy to mention that triorganotin(IV) compounds
4–6 were found to inhibit LOX activity and anti-proliferate
sarcoma cells stronger than di-organotins. Between
diorganotin(IV) derivatives of o-H2BZA 1 and 2, the
dibutyltin complex exhibits signiﬁcant stronger cytotoxic
activity than the corresponding one of dimethyltin complex.
This is also observed in the case of substituted salicylic
acids reported previously [34], where diethyl derivatives
were found to show approximately 10 times lower activity
than the corresponding dibutyltin complexes against
human mammary tumor cell lines (MCF-7) and human
colon carcinoma cell line (WiDr) [34]. The corresponding
IC50 values of other organotin(IV) complexes found
against leiomyosarcoma cells were 5 and 125nm for
[(C6H5)3Sn(MNA)Sn(C6H5)3(acetone)] (H2MNA = 2-
mercapto-nicotinic acid) [14], and [(n-Bu)3Sn(TBA)·H2O]8 Bioinorganic Chemistry and Applications
Table 4: IC50 values for LOX inhibition activity and cell cytotoxic activity of organotin(IV) complexes 1–6.
Compound IC50 for LOX inhibition IC50 cell activity Ref
[(CH3)2Sn(o-HBZA)2] (1) 76μm >2000nm [∗]
[(n-C4H9)2Sn(o-HBZA)2] (2) 48μm 150nm [∗]
[(n-C4H9)3Sn(o-HBZA)] (3) 82μm 150nm [∗]
[(C6H5)3Sn(o-HBZA)] (4) 19μm5 - 1 0 n m [ ∗]
[(n-C4H9)3Sn(p-HBZA)] (5) 24μm 30-40nm [∗]
[(C6H5)3Sn(p-HBZA)] (6) 11μm 25-35nm [∗]
(n-Bu)3Sn(TBA) ·H2O] 25μm 125 nM [14]
[(C6H5)3Sn(MNA)Sn(C6H5)3(acetone)] 14μm 5nm [14]
[(C6H5)3Sn(MBZT)] 19μm 1500–3000nm [15]
[(C6H5)3Sn(MBZO)] 16μm 1300–3000nm [15]
[(C6H5)3Sn(CMBZT)] 21μm 500–800nM [15]
[(C6H5)2Sn(CMBZT)2]1 0 μm 300–500nm [15]
[(n-C4H9)2Sn(CMBZT)2]1 3 μm 600–800nm [15]
[(CH3)2Sn(CMBZT)2]1 4 μm 5000–7500nm [15]
[(CH3)2Sn(PMT)2]6 1 μm 20000–60000nm [16]
[(n-C4H9)2Sn(PMT)2]2 6 μm 700nm [16]
[(C6H5)2Sn(PMT)2]2 1 μm 1000–2000nm [16]
[(C6H5)3Sn(PMT)] 17μm 100nm [16]
[∗]: This work; HTBA: 2-thiobarbituric acid; H2MNA: 2-mercapto-nicotinic acid; MBZT: 2-mercapto-benzothiazole; MBZO: 2-mercapto-benzoxazole;
CMBZT: 5-chloro-2-mercapto-benzothiazole; HPMT: 2-mercapto-pyrimidine.
(HTBA = 2-thiobarbituric acid) [14], 1500–3000,
1300–3000, and 500–800nm for [(C6H5)3Sn(MBZT)],
[(C6H5)3Sn(MBZO)], [(C6H5)3Sn(CMBZT)] (MBZT
= 2-mercapto-benzothiazole, MBZO = 2-mercapto-
benzoxazole and CMBZT = 5-chloro-2-mercapto-
benzothiazole) [15], 300–500, 600–800, and 5000–7500nm
for [(C6H5)2Sn(CMBZT)2], [(n-C4H9)2Sn(CMBZT)2],
and [(CH3)2Sn(CMBZT)2], [15] and 20000–60000,
700, 1000–2000, and 100nm for [(CH3)2Sn(PMT)2],
[(n-C4H9)2Sn(PMT)2], [(C6H5)2Sn(PMT)2], and
[(C6H5)3Sn(PMT)] (PMT = 2-mercapto-pyrimidine),
[16]. From all of these values for the diﬀerent compounds,
it is clear that complexes 1–6 have high cytotoxic activity
against leiomyosarcoma cells. Triphenylorganotin(IV)
complexes 4 and 6 are the most active compounds of this
series of compounds (where the IC50 are 5–10nm for 4 and
25–35nm for 6) and they are classiﬁed among the most
active organotin(IV) compounds tested.
Table 4 summarizes the IC50 (μm) values for LOX
inhibition in comparison with cell activity of organotin(IV)
complexes 1–6 against sarcoma cells.
2.6. Computational Methods–Docking Study. In order to
investigate further the complex-LOX interactions, we per-
formed computational molecular docking studies for the
complexes 1 and 2 were X-ray data are available. The binding
energy (E) of the substrate (S: linoleic acid) to its binding site
in the enzyme LOX (E) when ES is the complex formed was
E: −7.89kcal/mole[13].Thecorrespondingbindingenergies
of inhibitors 1 and 2 (I), in ESI, are calculated to −8.48
(1)a n d−8.23 (2)kcal/mol, respectively, while the binding
energies of EI are estimated to −9.7Kcal/mol(1)a n d−11.4
(2)kcal/mol. According to the binding energy (E)v a l u e so f
ES in contrast to those of EI or ESI, it is found that both ESI
a n dE Ic o m p l e x e sc o u l db ef o r m e d .
Figures 3 and 4 show the binding site of compound 1
toward LOX in ESI and EI, respectively. Compounds 1 and
2 bind to both ESI and EI complexes at the same pocket
where the strong inhibitors of LOX bind [15], supporting its
strong inhibition activity, found experimentally. Since high
inhibition activity of LOX has been detected for all cytotoxic
organotin(IV)-thione compounds tested previously, [13–
17] strong activity would also be expected for compounds
1 and 2, although weaker than the others, tested in this
study.
3. Conclusion
Organotin(IV) complexes (1)–(7) are found to inhibit
strongly the peroxidation of linoleic acid by the enzyme
lipoxygenase. Five-coordinated organotin(IV) complexes 6,
4, and 5 (IC50 = 11, 19, and 24μm, resp.) showed
strongestLOXinhibitionactivitythanthecorrespondingsix-
coordinated one (Table 4). Compounds 1–6, also, showed
strong antitumor activity against sarcoma cells (Table 4).
The highest antiproliferate activity against sarcoma cell
lines is also shown by the ﬁve-coordinated triphenyltin(IV)
complexes 4 and 6 (IC50 = 5–10 and 25–35nm, resp.).Bioinorganic Chemistry and Applications 9
(a)
(b)
Figure 3: Binding sites of inhibitor 1 toward LOX in ESI and EI, respectively.
Between tri- and diorganotin complexes, ﬁve-coordinated
organotin complexes which have one free coordination
position were found to exhibit stronger antiproliferative and
LOX inhibition activity. These ﬁndings are in accordance
to Huber et al. [12] who suggested that the structures
of organotin carboxylates antitumor active compounds are
characterized by (i) the availability of coordination positions
at Sn and (ii) the occurrence of relatively stable ligand-Sn
bonds, for example, Sn-N and Sn-S and their slow hydrolytic
decomposition. Therefore, the geometrical feature of this
typeofcomplexes(1–6)seemstoplayimportantroleintheir
antitumor and LOX inhibition activity.
4. Experimental
4.1. Materials and Instruments. A l ls o l v e n t su s e dw e r eo f
reagent grade, while o-, p-hydroxybenzoic acid, and organ-
otins chlorides (Alderich,USA), (Merck, Germany) were
used with no further puriﬁcation. Elemental analysis for
Ca n dHw a sc a r r i e do u tw i t haC a r l oE r b aE AM O D E L
1108. Infrared spectra in the region of 4000-370cm−1 were
obtained in KBr discs. The 119Sn M¨ ossbauer spectra were
collected at 80K, with a constant acceleration spectropho-
tometer equipped with CaSnO3 source kept at low temper-
ature. A Jasco UV/Vis/NIR V570 series spectrophotometer10 Bioinorganic Chemistry and Applications
Figure 4
was used to obtain electronic absorption spectra. The 1H-
NMR spectra were recorded on a Bruker AC250 MHFT
NMR instrument in DMSO-d6 solution. Chemical shifts
δ are reported in ppm using 1H TMS as an internal
reference.
Preparation of the Complexes [(CH3)2Sn(o-HBZA)2] (1),
[(n-C4H9)2Sn(o-HBZA)2] (2), [(n-C4H9)3Sn(o-HBZA)2]
(3), [(C6H5)3Sn(o-HBZA)2] (4), [(n-C4H9)3Sn(p-HBZA)2]
(5), and [(C6H5)3Sn(p-HBZA)2] (6). Complexes 1-2 were
synthesized as follows: a suspension of the ligand (o-
hydroxybenzoic acid, 0.138gr, 1mmol 1-2)i n5 c m −3 dis-
tilled water was treated with a solution of KOH 1N (1cm−3,
1mmol 1-2) and a clear solution was immediately formed.
5cm −3 methanolic solution of diorganotin(IV) chloride
((CH3)2SnCl2,0.109gr ,0.5mmolfor1and(n-C4H9)2SnCl2,
0.152gr, 0.5mmol for 2) was then added to the above solu-
tion. A white precipitate formed and the mixture was stirred
for4hours.Theprecipitatewasthenﬁlteredoﬀ,washedwith
3mL of distilled water and dried in vacuo over silica gel.
Crystalsof 1and2complexessuitableforX-rayanalysiswere
growth by slow evaporation of CH3OH/CH3CN solutions
(1 : 1). Complexes 3–6 were synthesized as follows: a sus-
pension of the ligand (o-, p-hydroxybenzoic acid, 0.069gr,
0.5mmol 3–6)i n5c m −3 distilled water was treated with a
solution of KOH 1N (0.5cm−3, 0.5mmol 3–6)a n dac l e a r
solution was immediately formed. 5cm−3 methanolic solu-
tion of triorganotin(IV) chloride ((n-C4H9)3SnCl, 135.6μL,
0.5mmol for 3 and 5,( C 6H5)3S n C l ,0 . 1 9 3g r ,0 . 5m m o lf o r
4 and 6) was then added to the above solution. A white
precipitate formed and the mixture was stirred for 4 hours.
The precipitate was then ﬁltered oﬀ, washed with 3mL of
distilled water, and dried in vacuo over silica gel.
1 Yield 70.25%, mp > 250
◦C. Elemental analysis found C
45.21, H 3.95%; calcd for C16H16O6Sn C 45.4, H 3.81%. IR
(cm−1): 3467, 1631, 1444, 1388, 1157, 870, 700 580, 536, 446.
1H-NMR (DMSO-d6 , ppm): δ 10.18 (s, 1H, phenolic OH),
7.83, 6.82 (d, 4H, C6H4CO2OH), 0.83 (s, 6H, Sn-CH3).
2 Yield 65%, mp 63
◦C. Elemental analysis found C 52.53,
H 5.43%; calcd for C22H28O6Sn C 52.1, H 5.56%. IR (cm−1):
3450, 1628, 1419, 1334, 1159, 869, 702, 562, 530, 435. 1H-
NMR (DMSO-d6 , ppm): δ 10.16 (s, 1H, phenolic OH), 7.69,
6.75 (d, 4H, C6H4CO2OH), 0.86, 1.18, and 1.60 (t, m, 9H,
Sn-C4H9).
3 Yield 55.30%, mp > 250
◦C. Elemental analysis found C
53.95, H 7.42%; calcd for C19H32O3Sn C 53.43, H 7.55%. IR
(cm−1):3450,1633,1458,1352,1157,866,703,564,538,445.
1H-NMR (DMSO-d6 , ppm): δ 9.91 (s, 1H, phenolic OH),
7.78, 6.66 (d, 4H, C6H4CO2OH), 0.88, 1.20, and 1.62 (t, m,
9H, Sn-C4H9).
4 Yield 54.35%, mp 160
◦C. Elemental analysis found C
61.78, H 3.98%; calcd for C25H20O3Sn C 61.64, H 4.14%. IR
(cm−1): 3447, 1636, 1458, 1356, 1160, 863, 729, 600, 533,
420. 1H-NMR (DMSO-d6 , ppm): δ 9.95 (s, 1H, phenolic
OH), 7.72, 6.73 (d, 4H, C6H4CO2OH), 7.40–7.64 (m, 15H,
Sn-C6H5).
5 Yield 75.40%, mp > 285
◦C. Elemental analysis found
C 53.66, H 8.25%; calcd for C19H32O3Sn C 53.43, H
7.55%. IR (cm−1): 3190, 1636, 1458, 1419, 1165, 854, 702,
610, 509, 458. 1H-NMR (DMSO-d6, ppm): δ 9.87 (s, 1H,
phenolic OH), 7.81, 6.69 (d, 4H, C6H4CO2OH), 0.90, 1.29,
and 1.69 (t, m, 9H, Sn-C4H9). 119Sn-NMR: -20. UV-Vis
(solvent)λmax (ε):(DMSO)237(11418),(CHCl3)228(9796)
and (MeOH) 227 (15576). ESI-MS (MeOH, m/z): 450.0
[{(n-C4H9)3Sn(p-HBZA)} +N a ]
+, 370.0 [(M)-(C4H9)]
+,
336.0 [(M)-(C4H9)2]
+, and 284.0 [{(M)-(C4H9)3}+N a]
+.
6 Yield 50.05%, mp 160
◦C. Elemental analysis found
C 61.96, H 4.20%; calcd for C25H20O3Sn C 61.64, H
4.14%. IR (cm−1): 3234, 1617, 1431, 1347, 1166, 857,
695, 569, 511, 450. 1H-NMR (DMSO-d6 , ppm): δ 9.89
(s, 1H, phenolic OH), 7.75, 6.76 (d, 4H, C6H4CO2OH),
7.42–7.66 (m, 15H, Sn-C6H5). 119Sn-NMR: -212. UV-VisBioinorganic Chemistry and Applications 11
(solvent)λmax (ε):(DMSO)234(5998),(CHCl3)232(13123)
and (MeOH) 225 (9695) ESI-MS (MeOH, m/z): 510.0
[{(C6H5)3Sn(p-HBZA)}+Na]
+ ions,434.0[{(M)-(C6H5)}+
Na]
+,and 356.0 [{(M)-(C6H5)2}+N a]
+.
4.2. Study of the Lipoxygenase Inhibition and Biological
Tests. Experimental details for LOX inhibition activity of
complexes 1–6 and their in vitro cells toxicity studies were
described earlier [13–15].
4.3.ComputationalDetails. Computationaldetailshavebeen
described elsewhere [13–15].
4.4. X-Ray Structure Determination. Data were collected by
the ω scan technique in the range 4.86
◦ < 2θ<24.71
◦on
a KUMA KM4CCD four-circle diﬀractometer [37]w i t h
CCD detector, using graphite-monochromated Mo Kα (λ =
0.71073 ˚ A) at 293(2)K. Cell parameters were determined by
a least-squares ﬁt [38] .A l ld a t aw e r ec o r r e c t e df o rL o r e n t z -
polarization eﬀects and absorption [38, 39].
The structure was solved with direct methods with
SHELXS97 [40] and reﬁned by full-matrix least-squares
procedures on F2 with SHELXL97 [41]. All nonhydrogen
atoms were reﬁned anisotropically, hydrogen atoms were
located at calculated positions and reﬁned as a “riding
model” with isotropic thermal parameters ﬁxed at 1.2 times
the Ueq of appropriate carrier atom.
1. C16H16O6Sn: MW = 423.00, monoclinic, P21/n, a
= 7.5321(3) ˚ A, b = 21.8775(7) ˚ A, c = 10.4440(4) ˚ A, β =
105.505(4), V = 1658.37(11) ˚ A, Z = 4, T = 293(1)K, ρ(cald)
= 1.694gcm−3, μ = 1.6mm−1, R = 0.0218, wR = 0.0540.
2. C22H26O6Sn: MW = 505.14, monoclinic, P21/c, a
= 9.3545(16) ˚ A, b = 24.135(4) ˚ A, c = 10.8625(18) ˚ A, β =
107.781(18), V = 2335.3(7) ˚ A, Z = 4, T = 293(1)K, ρ(cald)
= 1.440gcm−3, μ = 1.1mm−1, R = 0.0483, wR = 0.1007.
Crystallographic data (excluding structure factors) for
the structures reported in this paper have been deposited
with the Cambridge Crystallographic Data Centre as sup-
plementary publication nos. CCDC 705791 (1) and CCDC
705792 (2). Copies of the data can be obtained free of charge
on application to CCDC (Cambridge, UK).
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